scholarly journals Diabetes Detection and Prevention in Dermatology

2021 ◽  
pp. e2021131
Author(s):  
Alexandra Ngo ◽  
Luise Froessl ◽  
John Wesley McWhorter ◽  
William Brett Perkison ◽  
Rajani Katta
Keyword(s):  
Primary Care ◽  
At Risk ◽  
Primary Care Physician ◽  
Diabetes Prevention ◽  
The United States ◽  
Care Physician ◽  
Current Data ◽  
Cutaneous Manifestations ◽  
Screening Guidelines ◽  
Increased Risk

We are currently in the midst of an international epidemic of diabetes mellitus (DM) and prediabetes. The prevalence of DM in the United States is estimated at 9.4% of the population across all ages, while an estimated 1 in 3 Americans (33.9%) has prediabetes. According to the WHO, about 60 million people suffer from diabetes in the European Region. Dermatologists may play an important role in tackling this epidemic via efforts to improve early detection of both diabetes and prediabetes. Dermatologists often treat patients with, or at risk of, diabetes. This includes patients who present with cutaneous manifestations such as acanthosis nigricans, as well as patient populations at increased risk, including those with psoriasis, hidradenitis suppurativa, and polycystic ovarian syndrome. Simple screening guidelines can be used to identify patients at risk, and screening can be performed via a single non-fasting blood test. The diagnosis of prediabetes is a key feature in diabetes prevention, as interventions in this group can markedly reduce progression towards diabetes. In addition to referral to a primary care physician, dermatologists may refer these patients directly to structured behavioral lifestyle intervention programs known as diabetes prevention programs. A significant portion of the population lacks routine care by a primary care physician, and current data indicates need for improvement in diabetes screening and prevention among patient groups such as those with psoriasis. These factors highlight the importance of the dermatologist’s role in the detection and prevention of diabetes.

Review of Breast Screening Guidelines and Disease Management for the Primary Care Physician

2016 ◽  
Vol 2 (8) ◽  
Author(s):  
Linda M Sanders
Keyword(s):  
Breast Cancer ◽  
Primary Care ◽  
Primary Care Physician ◽  
Breast Density ◽  
Task Force ◽  
Nipple Discharge ◽  
The United States ◽  
Care Physician ◽  
Masking Effect ◽  
Screening Guidelines

This review article discusses the most recent recommendations for screening for breast cancer issued by the United States Preventitive Services Task Force in January 2016 and the criticisms of those recommendations.   This article also reviews the most common breast complaints seen by the primary care physician, including the inflamed breast, palpable concerns, and nipple discharge.  Included is a discussion of "the dense breast" which has become a national issue.  28 states have passed breast density laws designed to raise awareness of the masking effect of increased breast density on mammogram on the detection of breast cancer.

scholarly journals Medical Cannabis for the Primary Care Physician

2019 ◽  
Vol 10 ◽  
pp. 215013271988483 ◽  
Author(s):  
Deepika Slawek ◽  
Senthil Raj Meenrajan ◽  
Marika Rose Alois ◽  
Paige Comstock Barker ◽  
Irene Mison Estores ◽  
...  
Keyword(s):  
Primary Care ◽  
Primary Care Physician ◽  
Primary Care Physicians ◽  
The United States ◽  
Care Physician ◽  
Chronic Health Conditions ◽  
Health Conditions ◽  
Efficacy And Safety ◽  
Medical Cannabis ◽  
Number Of Patients

Medical cannabis use is common in the United States and increasingly more socially acceptable. As more patients seek out and acquire medical cannabis, primary care physicians will be faced with a growing number of patients seeking information on the indications, efficacy, and safety of medical cannabis. We present a case of a patient with several chronic health conditions who asks her primary care provider whether she should try medical cannabis. We provide a review of the pharmacology of medical cannabis, the state of evidence regarding the efficacy of medical cannabis, variations in the types of medical cannabis, and safety monitoring considerations for the primary care physician.

scholarly journals PRM99 - TRENDS IN OPIOID PRESCRIBING IN PRIMARY CARE PHYSICIAN OFFICES IN THE UNITED STATES: 2006-2015

2018 ◽  
Vol 21 ◽  
pp. S372
Author(s):  
MY Alsheikh ◽  
E. Seoane-Vazquez ◽  
A Barrett ◽  
C Rakovski ◽  
LM Brown ◽  
...  
Keyword(s):  
United States ◽  
Primary Care ◽  
Primary Care Physician ◽  
The United States ◽  
Care Physician ◽  
Opioid Prescribing

scholarly journals Predictors of Primary Care Physician Practice Location in Underserved Urban or Rural Areas in the United States

2016 ◽  
Vol 91 (9) ◽  
pp. 1313-1321 ◽  
Author(s):  
Amelia Goodfellow ◽  
Jesus G. Ulloa ◽  
Patrick T. Dowling ◽  
Efrain Talamantes ◽  
Somil Chheda ◽  
...  
Keyword(s):  
United States ◽  
Primary Care ◽  
Primary Care Physician ◽  
Rural Areas ◽  
The United States ◽  
Care Physician ◽  
Physician Practice ◽  
Practice Location

scholarly journals Association of Primary Care Physician Supply With Population Mortality in the United States, 2005-2015

2019 ◽  
Vol 179 (4) ◽  
pp. 506 ◽  
Author(s):  
Sanjay Basu ◽  
Seth A. Berkowitz ◽  
Robert L. Phillips ◽  
Asaf Bitton ◽  
Bruce E. Landon ◽  
...  
Keyword(s):  
United States ◽  
Primary Care ◽  
Primary Care Physician ◽  
The United States ◽  
Care Physician ◽  
Physician Supply ◽  
Population Mortality

Primary care physician compliance with colorectal cancer screening guidelines

2011 ◽  
Vol 22 (9) ◽  
pp. 1277-1287 ◽  
Author(s):  
Jesse N. Nodora ◽  
William D. Martz ◽  
Erin L. Ashbeck ◽  
Elizabeth T. Jacobs ◽  
Patricia A. Thompson ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Primary Care ◽  
Cancer Screening ◽  
Primary Care Physician ◽  
Colorectal Cancer Screening ◽  
Care Physician ◽  
Screening Guidelines ◽  
Physician Compliance

Prevalence of cardiovascular disease (CVD) risk factors and receipt of preventive care among prostate cancer (CaP) survivors in the United States.

2013 ◽  
Vol 31 (6_suppl) ◽  
pp. 185-185
Author(s):  
Kevin Alexander Pearlstein ◽  
Laura H. Hendrix ◽  
Trevor Joseph Royce ◽  
William A. Stokes ◽  
Ronald C. Chen
Keyword(s):  
Risk Factors ◽  
Primary Care ◽  
Primary Care Physician ◽  
Preventive Care ◽  
National Health ◽  
The United States ◽  
Population Based ◽  
Care Physician ◽  
Cvd Risk Factors ◽  
Cvd Risk

185 Background: CVD is a major cause of mortality in CaP survivors. Prior claims-based studies have reported underutilization of preventive care in cancer survivors, but most CVD preventive care items are not available in claims data. We directly examined the prevalence of CVD risk factors and receipt of care in patients with these risk factors in two population-based data sources: National Health and Nutrition Examination Survey (NHANES) and National Health Interview Survey (NHIS) – both commonly used to examine patterns of care in the US. Methods: 2,938 (NHANES) and 452 (NHIS) men with CaP diagnosed from 1999 to 2011 were included. Statistical analysis accounted for sampling weight, and was stratifiedby Caucasian (CA) vs. non-CA. Results: CVD risk factors are highly prevalent (Table), and appear more so in non-Caucasian survivors. Further, 32% of survivors reported history of actual CVD (prior stroke, myocardial infarction, angina, or coronary heart disease). Overall, the majority of survivors receive preventive care. 89%of CA and non-CA survivors visited a primary care physician in the past 1 year. Among survivors with hypertension or hyperlipidemia, >80% received blood pressure or cholesterol checks within past 1 year. Rates of tobacco cessation and exercise were lower. Conclusions: CVD and associated risk factors are prevalent in CaP survivors. However, the majority of these survivors visit a primary care physician and receive CVD preventive care. [Table: see text]

Sign in / Sign up

Export Citation Format

Share Document